PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
1.69%
Some net income increase while MRVL is negative at -13426.47%. John Neff would see a short-term edge over the struggling competitor.
8.51%
Less D&A growth vs. MRVL's 265.59%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
245.45%
Deferred tax of 245.45% while MRVL is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
No Data
No Data available this quarter, please select a different quarter.
-121.93%
Both reduce yoy usage, with MRVL at -223.22%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
-18.13%
Both reduce yoy inventory, with MRVL at -456.19%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
No Data
No Data available this quarter, please select a different quarter.
-156.16%
Negative yoy usage while MRVL is 110.08%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
171.66%
Growth of 171.66% while MRVL is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might reflect intangible expansions or partial write-offs.
133.53%
Some CFO growth while MRVL is negative at -41.38%. John Neff would note a short-term liquidity lead over the competitor.
24.36%
Some CapEx rise while MRVL is negative at -27.98%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
-48.90%
Negative yoy purchasing while MRVL stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
19.15%
Liquidation growth of 19.15% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
-56.71%
We reduce yoy invests while MRVL stands at 33108.21%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
200.00%
Stock issuance far above MRVL's 100.00%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
44.08%
Buyback growth of 44.08% while MRVL is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.